158 related articles for article (PubMed ID: 12584177)
1. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.
Zheng YL; Loffredo CA; Yu Z; Jones RT; Krasna MJ; Alberg AJ; Yung R; Perlmutter D; Enewold L; Harris CC; Shields PG
Carcinogenesis; 2003 Feb; 24(2):269-74. PubMed ID: 12584177
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin-induced mutagen sensitivity, passive smoking, and risk of breast cancer in Chinese women: a case-control study.
Hu M; Han D; Sun S; Yan Y; Zhang J; Zhou Y
Cancer Causes Control; 2013 Apr; 24(4):629-36. PubMed ID: 23371556
[TBL] [Abstract][Full Text] [Related]
3. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes.
Cloos J; Nieuwenhuis EJ; Boomsma DI; Kuik DJ; van der Sterre ML; Arwert F; Snow GB; Braakhuis BJ
J Natl Cancer Inst; 1999 Jul; 91(13):1125-30. PubMed ID: 10393720
[TBL] [Abstract][Full Text] [Related]
4. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
[TBL] [Abstract][Full Text] [Related]
5. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.
Wu X; Hsu TC; Annegers JF; Amos CI; Fueger JJ; Spitz MR
Cancer Res; 1995 Feb; 55(3):557-61. PubMed ID: 7530597
[TBL] [Abstract][Full Text] [Related]
7. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
[TBL] [Abstract][Full Text] [Related]
8. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
[TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
[TBL] [Abstract][Full Text] [Related]
10. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.
Wu X; Yu H; Amos CI; Hong WK; Spitz MR
J Natl Cancer Inst; 2000 May; 92(9):737-43. PubMed ID: 10793110
[TBL] [Abstract][Full Text] [Related]
11. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
12. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.
Wu X; Gu J; Patt Y; Hassan M; Spitz MR; Beasley RP; Hwang LY
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):567-70. PubMed ID: 9681523
[TBL] [Abstract][Full Text] [Related]
13. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
Cloos J; Snow GB; Braakhuis BJ
Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
[TBL] [Abstract][Full Text] [Related]
14. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
15. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans.
Spitz MR; Hsu TC; Wu X; Fueger JJ; Amos CI; Roth JA
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):99-103. PubMed ID: 7537995
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans.
Strom SS; Wu S; Sigurdson AJ; Hsu TC; Fueger JJ; Lopez J; Tee PG; Spitz MR
J Natl Cancer Inst Monogr; 1995; (18):29-33. PubMed ID: 8562219
[TBL] [Abstract][Full Text] [Related]
17. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
18. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers.
Spitz MR; Fueger JJ; Beddingfield NA; Annegers JF; Hsu TC; Newell GR; Schantz SP
Cancer Res; 1989 Aug; 49(16):4626-8. PubMed ID: 2472882
[TBL] [Abstract][Full Text] [Related]
19. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk.
Wu X; Hsu TC; Cao S; Lee JJ; Amos CI; Spitz MR
Carcinogenesis; 1998 Jan; 19(1):93-8. PubMed ID: 9472699
[TBL] [Abstract][Full Text] [Related]
20. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.
Spitz MR; Fueger JJ; Halabi S; Schantz SP; Sample D; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):329-33. PubMed ID: 7688625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
